Items where Author is "Albersen, Maarten"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Journal Article

Milenkovic, Uros, Boeckx, Bram, Lambrechts, Diether, Janky, Rekin’s, Hatzichristodoulou, Georgios, van Renterghem, Koen, Gevaert, Thomas, Cellek, Selim, Bivalacqua, Trinity J., De Ridder, Dirk and Albersen, Maarten (2021) Single-cell Transcriptomics Uncover a Novel Role of Myeloid Cells and T-lymphocytes in the Fibrotic Microenvironment in Peyronie’s Disease. European Urology Focus. ISSN 2405-4569

Weyne, Emmanuel, Ilg, Marcus M., Cakir, Onur Omer, Muneer, Asif, Roussel, Delphine Behr, Albersen, Maarten, Angulo, Javier, Corona, Giovanni, Bettocchi, Carlo, Reisman, Yacov and Castiglione, Fabio (2020) European Society for Sexual Medicine Consensus Statement on the Use of the Cavernous Nerve Injury Rodent Model to Study Postradical Prostatectomy Erectile Dysfunction. Sexual Medicine, 8 (3). pp. 327-337. ISSN 2050-1161

Milenkovic, Uros, Ilg, Marcus M., Cellek, Selim and Albersen, Maarten (2019) Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie’s Disease. Sexual Medicine Reviews, 7 (4). pp. 679-689. ISSN 2050-0521

Milenkovic, Uros, Ilg, Marcus M., Zuccato, Carola, Ramazani, Yasaman, De Ridder, Dirk and Albersen, Maarten (2019) Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie's disease-derived fibroblasts via inhibition of YAP/TAZ nuclear translocation. BJU International, 123 (4). pp. 703-715. ISSN 1464-410X

Milenkovic, Uros, Ilg, Marcus M., Cellek, Selim and Albersen, Maarten (2019) What role do pharmaceuticals play in the treatment of Peyronie’s disease and is there a need for new emerging drugs? Expert Opinion on Emerging Drugs, 24 (1). pp. 1-4. ISSN 1472-8214

Ilg, Marcus M., Mateus, Marta, Stebbeds, William J., Milenkovic, Uros, Christopher, Nim, Muneer, Asif, Albersen, Maarten, Ralph, David J. and Cellek, Selim (2019) Antifibrotic synergy between phosphodiesterase type 5 inhibitors and selective oestrogen receptor modulators in Peyronie’s disease models. European Urology, 75 (2). pp. 329-340. ISSN 1873-7560

This list was generated on Sat Oct 1 02:15:55 2022 BST.